Ratings ERAMET S.A. OTC Markets

Equities

ERMAY

US29478X1090

Market Closed - OTC Markets 01:37:40 2024-04-23 pm EDT 5-day change 1st Jan Change
7.97 USD 0.00% Intraday chart for ERAMET S.A. +3.44% +2.71%

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • With a P/E ratio at 13.96 for the current year and 4.96 for next year, earnings multiples are highly attractive compared with competitors.
  • With regards to fundamentals, the enterprise value to sales ratio is at 0.9 for the current period. Therefore, the company is undervalued.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Over the past twelve months, analysts' opinions have been strongly revised upwards.

Weaknesses

  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
  • Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
  • The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Diversified Mining

1st Jan change Capi. Investor Rating ESG Refinitiv
+2.71% 2.29B -
-9.74% 148B
C+
-8.99% 114B
C
-0.76% 71.19B
C+
+7.72% 52.64B
B+
+6.91% 46.6B
B
+7.12% 32.32B
C+
+11.05% 23.72B
B-
+27.03% 20.76B
A-
+41.17% 17.31B -
C+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes